Eikon Therapeutics announces appointment of Michael Klobuchar as Chief Operating Officer
HAYWARD, Calif. — (BUSINESS WIRE) — #Biotech — Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, recently announced that Michael A. Klobuchar has been appointed Chief Operating Officer. He joins Eikon from
